Combining immune checkpoint inhibition and DNA damage repair (DDR) targeted therapy in small cell lung cancer (SCLC)

Sen, T; Chen, LM; Rodriguez, BL; Yang, YB; Fan, YH; Stewart, CA; Glisson, B; Piwnica-Worms, H; Sage, J; Heymach, JV; Gibbons, DL; Byers, LA

CANCER IMMUNOLOGY RESEARCH, 2017; 5 (3):